Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 1, 2006, Pages 67-72

  Lin, Yi Chun ^a   Chen, Te Li ^b   Ju, Huang Ling ^b   Chen, Huan Shen ^c   Wang, Fu Der ^b,d   Yu, Kwok Woon ^b   Liu, Chen Yi ^b  

^a TAICHUNG HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c LI SHIN HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Bacteremia; Comorbidity; Enterobacter cloacae; Prognosis; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENTEROBACTER CLOACAE; GASTROINTESTINAL TRACT; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORTALITY; NEOPLASM; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEPTIC SHOCK; STRATIFICATION; UNIVARIATE ANALYSIS; UROGENITAL SYSTEM; BLOOD; CHILD; CROSS INFECTION; CULTURE MEDIUM; DRUG EFFECT; ENTEROBACTER INFECTION; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROGNOSIS;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; CHILD; CROSS INFECTION; CULTURE MEDIA; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 33645326003     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. 16th ed. New York: McGraw Hill; 2004:883-4.
2. Lee SO, Kim YS, Kim BN, Kim MN, Woo JH, Ryu J. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with Enterobacter bacteremia. Eur J Clin Microbiol Infect Dis 2002;21:577-81.
3. John JF Jr, Sharbaugh RJ, Bannister ER. Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. Rev Infect Dis 1982;4:13-28.
4. Maki DG. Nosocomial bacteremia. An epidemiologic overview. Am J Med 1981;70:719-32.
5. Bryan CS, Reynolds KL, Brenner ER. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983;5:629-38.
6. Flynn DM, Weinstein RA, Nathan C, Gaston MA, Kabins SA. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis 1987;156:363-8.
7. Fung CP, Wang LS, Juang YC, Liu CY, Cheng DL. Enterobacter cloacae bacteremia: clinical analysis of 41 cases. Zhonghua Yi Xue Za Zhi (Taipei) 1988;42:297-304.
8. Valero C, Garcia Palomo JD, Matorras P, Fernandez-Mazarrasa C, Gonzalez Fernandez C, Farinas MC. Acinetobacter bacteremia in a teaching hospital, 1989-1998. Eur J Intern Med 2001;12:425-9.
9. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7. 7th ed. Wayne (PA): The Committee; 2000.
10. Maiztegui JI, Biegeleisen JZ Jr, Cherry WB, Kass EH. Bacteremia due to gram-negative rods. A clinical, bacteriologic, serologic and immunofluorescent study. N Engl J Med 1965; 272:222-9.
11. Jang TN, Kuo BI, Shen SH, Fung CP, Lee SH, Yang TL, et al. Nosocomial gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Med Assoc 1999;98:465-73.
12. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
13. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-78.
14. Bouza E, Garcia de la Torre M, Erice A, Loza E, Diaz-Borrego JM, Buzon L. Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med 1985;145:1024-7.
15. Gupta N, Aparna, Choudhary U, Garg N, Arora DR. Enterobacter bacteremia. J Assoc Physicians India 2003;51: 669-72.
16. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
17. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995;274:968-74.
18. Uzun O, Akalin HE, Hayran M, Unal S. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis 1992;15:866-73.
19. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997;24:387-95.
20. Olson B, Weinstein RA, Nathan C, Kabins SA. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother 1983;11:299-310.
21. Shlaes DM. The clinical relevance of Enterobacter infections. Clin Ther 1993;15(Suppl A):21-8.
22. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis 1995;21:1107-13.
23. Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 2001;45:2628-30.
24. Liu CP, Wang NY, Lee CM, Weng LC, Tseng HK, Liu CW, et al. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J Hosp Infect 2004;58:63-77.